The Current Ratio as of December 2025 (TTM) for Astria Therapeutics, Inc. (ATXS) is 14.89

According to Astria Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.89. This represents a change of -17.47% compared to the average of 18.04 of the last 4 quarters.

Astria Therapeutics, Inc. (ATXS) Historical Current Ratio (quarterly & annually)

How has ATXS Current Ratio performed in the past?

The mean historical Current Ratio of Astria Therapeutics, Inc. over the last ten years is 12.89. The current 14.89 Current Ratio has changed 11.45% with respect to the historical average. Over the past ten years (40 quarters), ATXS's Current Ratio was at its highest in in the December 2022 quarter at 389.07. The Current Ratio was at its lowest in in the December 2017 quarter at 2.90.

Astria Therapeutics, Inc. (ATXS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Astria Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Astria Therapeutics, Inc. (ATXS) Average Current Ratio

How has ATXS Current Ratio performed in the past?

The current Current Ratio of Astria Therapeutics, Inc. (ATXS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Astria Therapeutics, Inc. (ATXS) Current Ratio vs. Peers

How is ATXS’s Current Ratio compared to its peers?

Astria Therapeutics, Inc.’s Current Ratio is greater than Erasca, Inc. (11.04), greater than MeiraGTx Holdings plc (0.22), greater than ArriVent BioPharma, Inc. Common Stock (12.74), less than MBX Biosciences, Inc. Common Stock (32.95), greater than Valneva SE (2.27), greater than Ginkgo Bioworks Holdings, Inc. (4.39), greater than Iovance Biotherapeutics, Inc. (3.27), greater than Arvinas, Inc. (5.70), greater than Replimune Group, Inc. (6.94), greater than Day One Biopharmaceuticals, Inc. (8.68),

Build a custom stock screener for Astria Therapeutics, Inc. (ATXS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Astria Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Astria Therapeutics, Inc. (ATXS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Astria Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.